Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.49

-0.39

-0.29

-0.19

Details

Expected EPS

-0.19

Actual EPS

-0.22

Surprise EPS

-0.03

Surprise Percent

+15.79%

Description

Aligos Therapeutics (ALGS) has reported earnings of -0.22 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.